Bank of Montreal (BMO)
Toronto Exchange · Canada · prices in CAD · close of 22 Oct 2026
Key indicators
| Last close | CAD 238.70 |
|---|---|
| 52-week range | 168.92 – 259.20 |
| Return, 1 month / 3 months | −2.7% / −4.7% |
| Return, 1 year / 3 years | +40.4% / +155.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 52 |
| Volatility (1 year) | 19.0% |
| Worst drawdown (1 year) | -11.4% |
| Average daily value traded | 490.19M CAD |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bank of Montreal is a Canadian chartered bank that provides personal and commercial banking, wealth management, and capital markets services. It serves individual customers, small businesses, and large corporations through a branch network in Canada and the United States, along with investment and insurance products. The bank is headquartered in Montreal, with major executive operations in Toronto, and it also maintains a presence in international markets.
On this site Bank of Montreal appears as a stock on the Toronto Exchange (Canada), code BMO, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bank of Montreal (BMO) trades on the Toronto Exchange in Canada. It last closed at CAD 238.70 on 22 October 2026.
Its price-based Market X-Ray is 79 out of 100 (a strong price profile), ranking 24 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 40.4% and over the last three months it fell 4.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.1% | ||
| From 52-week high | -7.4% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.7% | ||
| 6-month return | 17.4% | ||
| 12-month return, skipping the last month | 44.2% | ||
| Stability (higher is calmer) | 90 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -11.4% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 490.19M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.4% |
|---|---|
| 1 month | −2.7% |
| 3 months | −4.7% |
| 6 months | +17.4% |
| 1 year | +40.4% |
| 3 years | +155.6% |
| 5 years | +119.7% |
Signals
| 50-day / 200-day average | 240.73 / 218.75 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.77 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Oct 2026 | CAD 1.7100 |
| 30 Jul 2026 | CAD 1.7100 |
| 29 Apr 2026 | CAD 1.6700 |
| 30 Jan 2026 | CAD 1.6700 |
| 30 Oct 2025 | CAD 1.6300 |
| 30 Jul 2025 | CAD 1.6300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.